A growing number of states are threatening to take legal action against pharmacies that make or dispense unauthorized versions of the weight-loss medications Ozempic and Wegovy.
At least four states are already curbing the manufacturing of copycat versions over safety concerns and more could soon follow, experts say, as the two medications soar in popularity in the U.S.
Some compounding pharmacies in the U.S. have been offering what appears to be semaglutide — the active ingredient in both Ozempic and Wegovy — amid an ongoing shortage.
Read this story in its entirety on nbcnews.com.